Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Miklós Tamás Katona"'
Autor:
Miklós Tamás Katona, Lili Nagy-Katona, Réka Szabó, Enikő Borbás, Péter Tonka-Nagy, Krisztina Takács-Novák
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 753 (2023)
The purpose of this study was to investigate the applicability of the Gastrointestinal Simulator (GIS), a multi-compartmental dissolution model, to predict the in vivo performance of Biopharmaceutics Classification System (BCS) Class IIa compounds. A
Externí odkaz:
https://doaj.org/article/625742ff4aef4a27b1db3c24e0a8bb32
Autor:
Varun Kushwah, Sumit Arora, Miklós Tamás Katona, Dattatray Modhave, Eleonore Fröhlich, Amrit Paudel
Publikováno v:
Pharmaceutics, Vol 13, Iss 2, p 283 (2021)
The present work evaluates the food effect on the absorption of rivaroxaban (Riva), a BCS II drug, from the orally administered commercial immediate-release tablet (Xarelto IR) using physiologically based pharmacokinetic (PBPK) and conventional in vi
Externí odkaz:
https://doaj.org/article/5dd2bfeed150487588d5ebf770701d68
Autor:
Miklós Tamás Katona, Melinda Kakuk, Réka Szabó, Péter Tonka-Nagy, Krisztina Takács-Novák, Enikő Borbás
Publikováno v:
Pharmaceutical research. 39(1)
Purpose The aim of our work was to develop a biorelevant dissolution method for a better understanding of the in vivo performance of delayed-release tablet formulations. Methods The typical pH profile and residence times in the stomach and small inte
Autor:
Sumit Arora, Varun Kushwah, Amrit Paudel, Dattatray Modhave, Miklós Tamás Katona, Eleonore Fröhlich
Publikováno v:
Pharmaceutics
Volume 13
Issue 2
Pharmaceutics, Vol 13, Iss 283, p 283 (2021)
Volume 13
Issue 2
Pharmaceutics, Vol 13, Iss 283, p 283 (2021)
The present work evaluates the food effect on the absorption of rivaroxaban (Riva), a BCS II drug, from the orally administered commercial immediate-release tablet (Xarelto IR) using physiologically based pharmacokinetic (PBPK) and conventional in vi
Publikováno v:
Journal of Thermal Analysis and Calorimetry. 135:3043-3055
Bisoprolol fumarate is a beta blocker-type drug substance which has been well known for several decades. However, no relevant data can be found in the literature about its crystal polymorphism. The purpose of this paper was to present two anhydrous f